サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1291392

オンコロジーベースのIn-Vivo CRO市場：世界の産業動向、シェア、規模、成長機会、2023-2028年予測

Oncology Based In-Vivo CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 142 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.85円
オンコロジーベースのIn-Vivo CRO市場：世界の産業動向、シェア、規模、成長機会、2023-2028年予測
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 142 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要：

世界のオンコロジーベースのIn-Vivo CROの市場規模は、2022年に11億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に7.65%の成長率（CAGR）を示し、2028年までに18億米ドルに達すると予測しています。

腫瘍学とは、生検、内視鏡、X線、コンピュータ断層撮影（CT）、磁気共鳴画像（MRI）、陽電子放射断層撮影（PET）、超音波などを用いてがんを研究、診断、治療する医学の一分野を指します。また、がんの副作用に耐え、緩和するために、ホルモン療法、免疫療法、放射線療法、経口療法を患者に提供しています。現在、がん治療のための研究開発受託機関（CRO）による複数の治験薬の開発により、世界中でオンコロジーベースのIn-Vivo CROの需要が高まっています。

オンコロジーベースのIn-Vivo CROの市場動向：

世界中でがんの有病率が高まっていることが、市場を牽引する重要な要因の1つとなっています。また、世界各国の政府は、研究開発活動への投資を積極的に行っています。これに加えて、医薬品開発業務受託機関（CRO）によるがん治療に関する専門知識の向上が、市場の成長を後押ししています。また、デオキシリボ核酸（DNA）を操作し、生物の特性を変化させる遺伝子工学の技術革新が進んでいます。これは、細胞の増殖、成長、分化を制御するためのがん遺伝子研究への関心の高まりと相まって、市場にプラスの影響を与えています。これに加えて、医薬品が幅広く入手可能であることと、ヘルスケア産業の拡大が、オンコロジーベースのIn-Vivo CROの需要を世界的に喚起しています。これとは別に、受託研究機関（CRO）が提供するコスト効率は、社内調査と比較して、業界の投資家に有利な成長機会を提供しています。また、ヘルスケア業界では、がん患者の安全性を確保するために、遠隔医療やバーチャル臨床試験の導入が増加しています。これは、市場の成長を促進すると予測されます。

本レポートで回答した主な質問

  • 2022年のオンコロジーベースのIn-Vivo CROの世界市場規模は？
  • 2023年～2028年の世界のオンコロジーベースのIn-Vivo CRO市場の予想成長率は？
  • 世界のオンコロジーベースのIn-Vivo CRO市場を牽引する主要因は何か？
  • COVID-19が世界のオンコロジーベースのIn-Vivo CRO市場に与えた影響とは？
  • 適応症に基づく世界のオンコロジーベースのIn-Vivo CRO市場の内訳はどうなっていますか？
  • モデル別のオンコロジーベースのIn-Vivo CROの世界市場の内訳は？
  • オンコロジーベースのIn-Vivo CROの世界市場における主要地域はどこか？
  • 世界のオンコロジーベースのIn-Vivo CRO市場の主要企業はどこか？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者について
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な業界動向

第5章 オンコロジーベースのIn-Vivo CROの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 適応症別市場内訳

  • 血液がん
    • 市場動向
    • 市場予測
  • 固形がん
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 モデル別市場内訳

  • シンジェニック
    • 市場動向
    • 市場予測
  • ゼノグラフト
    • 市場動向
    • 市場予測
  • 患者由来ゼノグラフト（PDX）
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 アプリケーション別市場内訳

  • 病院
    • 市場動向
    • 市場予測
  • リハビリテーションセンター
    • 市場動向
    • 市場予測

第9章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Champions Oncology Inc.
    • Charles River Laboratories International Inc.
    • Crown Bioscience Inc.
    • Eurofins Scientific
    • Evotec SE
    • ICON Plc
    • Labcorp Drug Development（Laboratory Corporation of America Holdings）
    • Living Tumor Laboratory
    • Taconic Biosciences Inc.
    • The Jackson Laboratory
    • WuXi AppTec
    • Xentech
図表

List of Figures

  • Figure 1: Global: Oncology Based In-Vivo CRO Market: Major Drivers and Challenges
  • Figure 2: Global: Oncology Based In-Vivo CRO Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Oncology Based In-Vivo CRO Market: Breakup by Indication (in %), 2022
  • Figure 5: Global: Oncology Based In-Vivo CRO Market: Breakup by Model (in %), 2022
  • Figure 6: Global: Oncology Based In-Vivo CRO Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Oncology Based In-Vivo CRO Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Oncology Based In-Vivo CRO (Blood Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Oncology Based In-Vivo CRO (Blood Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Oncology Based In-Vivo CRO (Solid Tumors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Oncology Based In-Vivo CRO (Solid Tumors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Oncology Based In-Vivo CRO (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Oncology Based In-Vivo CRO (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Oncology Based In-Vivo CRO (Syngeneic) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Oncology Based In-Vivo CRO (Syngeneic) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Oncology Based In-Vivo CRO (Xenograft) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Oncology Based In-Vivo CRO (Xenograft) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Oncology Based In-Vivo CRO (Patient Derived Xenograft (PDX)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Oncology Based In-Vivo CRO (Patient Derived Xenograft (PDX)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Oncology Based In-Vivo CRO (Other Models) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Oncology Based In-Vivo CRO (Other Models) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Oncology Based In-Vivo CRO (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Oncology Based In-Vivo CRO (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Oncology Based In-Vivo CRO (Rehabilitation Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Oncology Based In-Vivo CRO (Rehabilitation Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: North America: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: North America: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: United States: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: United States: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Canada: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Canada: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Asia-Pacific: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Asia-Pacific: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: China: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: China: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Japan: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Japan: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: India: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: India: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: South Korea: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: South Korea: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Australia: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Australia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Indonesia: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Indonesia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Europe: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Europe: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Germany: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Germany: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: France: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: France: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: United Kingdom: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: United Kingdom: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Italy: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Italy: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Spain: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Spain: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Russia: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Russia: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Latin America: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Latin America: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Brazil: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Brazil: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Mexico: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Mexico: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Middle East and Africa: Oncology Based In-Vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Middle East and Africa: Oncology Based In-Vivo CRO Market: Breakup by Country (in %), 2022
  • Figure 74: Middle East and Africa: Oncology Based In-Vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Global: Oncology Based In-Vivo CRO Industry: SWOT Analysis
  • Figure 76: Global: Oncology Based In-Vivo CRO Industry: Value Chain Analysis
  • Figure 77: Global: Oncology Based In-Vivo CRO Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oncology Based In-Vivo CRO Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 3: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Model (in Million US$), 2023-2028
  • Table 4: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Oncology Based In-Vivo CRO Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Oncology Based In-Vivo CRO Market: Competitive Structure
  • Table 7: Global: Oncology Based In-Vivo CRO Market: Key Players
目次
Product Code: SR112023A5438

Market Overview:

The global oncology based in-vivo CRO market size reached US$ 1.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.65% during 2023-2028.

Oncology refers to a branch of medicine that studies, diagnoses, and treats cancer using biopsy, endoscopy, X-ray, computed tomography (CT) scanning, magnetic resonance imaging (MRI), positron emission tomography (PET) scanning, and ultrasound. It offers hormonal therapy, immunotherapy, radiotherapy, and oral therapies to patients for tolerating and easing the side effects of cancer. At present, there is a rise in the demand for oncology based in-vivo CRO across the globe due to the development of several investigational compounds by contract research organizations (CROs) for treating cancer.

Oncology Based In-Vivo CRO Market Trends:

The growing prevalence of cancer around the world represents one of the key factors driving the market. Moreover, governments of several countries across the globe are extensively investing in research and development (R&D) activities. This, along with the rising expertise in cancer treatment by contract research organizations (CROs), is propelling the growth of the market. In addition, there is an increase in the innovation of genetic engineering for manipulating deoxyribonucleic acid (DNA) and altering the characteristics of organisms. This, coupled with the growing focus on oncogene study to regulate proliferation, growth, and differentiation of cells, is positively influencing the market. Besides this, the wide availability of medicines, along with the expanding healthcare industry, is catalyzing the demand for oncology based in-vivo CRO worldwide. Apart from this, the cost-efficiency offered by contract research organizations (CROs) compared to an in-house study is offering lucrative growth opportunities to industry investors. Additionally, there is an increase in the adoption of telehealth and virtual clinical trials in the healthcare industry for ensuring the safety of cancer patients. This is projected to bolster the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global oncology based in-vivo CRO market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on indication, model and application.

Breakup by Indication:

  • Blood Cancer
  • Solid Tumors
  • Others

Breakup by Model:

  • Syngeneic
  • Xenograft
  • Patient Derived Xenograft (PDX)
  • Others

Breakup by Application:

  • Hospitals
  • Rehabilitation Centers

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Champions Oncology Inc., Charles River Laboratories International Inc., Crown Bioscience Inc., Eurofins Scientific, Evotec SE, ICON Plc, Labcorp Drug Development (Laboratory Corporation of America Holdings), Living Tumor Laboratory, Taconic Biosciences Inc., The Jackson Laboratory, WuXi AppTec and Xentech.

Key Questions Answered in This Report:

  • What was the size of the global oncology based in-vivo CRO market in 2022?
  • What is the expected growth rate of the global oncology based in-vivo CRO market during 2023-2028?
  • What are the key factors driving the global oncology based in-vivo CRO market?
  • What has been the impact of COVID-19 on the global oncology based in-vivo CRO market?
  • What is the breakup of the global oncology based in-vivo CRO market based on the indication?
  • What is the breakup of the global oncology based in-vivo CRO market based on the model?
  • What are the key regions in the global oncology based in-vivo CRO market?
  • Who are the key players/companies in the global oncology based in-vivo CRO market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Oncology Based In-Vivo CRO Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Indication

  • 6.1  Blood Cancer
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Solid Tumors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7   Market Breakup by Model

  • 7.1  Syngeneic
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Xenograft
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Patient Derived Xenograft (PDX)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4  Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8   Market Breakup by Application

  • 8.1  Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Rehabilitation Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9   Market Breakup by Region

  • 9.1  North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2  Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3  Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4  Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5  Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10  SWOT Analysis

  • 10.1  Overview
  • 10.2  Strengths
  • 10.3  Weaknesses
  • 10.4  Opportunities
  • 10.5  Threats

11  Value Chain Analysis

12  Porters Five Forces Analysis

  • 12.1  Overview
  • 12.2  Bargaining Power of Buyers
  • 12.3  Bargaining Power of Suppliers
  • 12.4  Degree of Competition
  • 12.5  Threat of New Entrants
  • 12.6  Threat of Substitutes

13  Price Analysis

14  Competitive Landscape

  • 14.1  Market Structure
  • 14.2  Key Players
  • 14.3  Profiles of Key Players
    • 14.3.1  Champions Oncology Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2  Charles River Laboratories International Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3  Crown Bioscience Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4  Eurofins Scientific
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5  Evotec SE
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6  ICON Plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7  Labcorp Drug Development (Laboratory Corporation of America Holdings)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8  Living Tumor Laboratory
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9  Taconic Biosciences Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10  The Jackson Laboratory
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11  WuXi AppTec
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12  Xentech
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio